Conference Coverage
Conference Coverage
‘Huge step forward’ in advanced ovarian cancer
A preplanned interim analysis revealed that the addition of durvalumab and olaparib was associated with a 37% improvement of PFS, compared with...
Conference Coverage
Omitting radiation in rectal cancer: ‘Less is more’
‘An all-chemotherapy approach may make curative intent treatment accessible for patients in these resource-constrained settings,’ says the author...
Conference Coverage
Phone support helps weight loss in patients with breast cancer
After 6 months, patients who received telephone coaching and health education lost 9.7 pounds.
Conference Coverage
Medicaid expansion closing racial gap in GI cancer deaths
Results of a new study were particularly notable for Black patients, for whom there was a consistent increase in receiving therapy and a decrease...
Latest News
Cross-border U.S.-Mexican collaboration drives up ALL survival
Conference Coverage
Chemo avoidance pays off for some women with HER2+ early BC
Almost all patients who skipped chemotherapy avoided invasive disease/death at 3 years.
Conference Coverage
Breast cancer: Meta-analysis supports ovarian suppression/ablation
Controlling estrogen seems to give premenopausal women a lifespan boost, but strategy remains uncommon.
Conference Coverage
SCLC: Bispecific antibody shows phase 1 promise
The antibody targets delta-like ligand 3, which is one of few surface markers for small cell lung cancer.
Conference Coverage
Surgical de-escalation passes clinical test in low-risk cervical cancer
‘Practice-changing’ results could reduce long-term survivor effects among qualifying patients.
Conference Coverage
Groundbreaking new regimen for advanced Hodgkin lymphoma
The immune checkpoint inhibitor nivolumab affords unprecedented improvement in “harmonizing” treatment for adult and pediatric Hodgkin lymphoma...